Trial Profile
Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2).
Status:
Suspended
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Urocortin 2 (Primary) ; Astressin; Substance P; Urocortin 3
- Indications Heart failure
- Focus Pharmacodynamics
- 10 May 2012 Planned end date changed from 1 Aug 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 14 Feb 2011 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
- 14 Feb 2011 Planned end date changed from 1 Feb 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.